Novo Nordisk is on the verge of losing patent protection in countries that are home to 40 percent of the world's population, with generics also expected to become available in the coming months in China, Canada, Brazil, Turkey and South Africa
Theyre sort of like alternatives when the patient cant take the brand name", explained NBC News medical contributor Dr
doi:10.1297/cpe.29.81 Horikawa Y, Enya M, Komagata M, et al
Side effects and dosing issues should be reported to the FDAs MedWatch
We have already received the regulators approval for both the indication of chronic weight management as well as treatment of type 2 diabetes under the brand name Noveltreat and Sematrinity respectively. Kirti Ganorkar, Managing Director, Sun Pharma | Q3 FY26 The honest part of this bet is that everyone running it knows exactly what it looks like